My Lords, as the Minister said, the process of manufacturing vaccines is complex and difficult, as we saw with Johnson & Johnson in America, for example. The fastest and best way to set up large-scale vaccine manufacturing in developing countries is for the rights holders to invest. Will our Government work with IP holders such as AstraZeneca to set up across the world? We do not need to deprive them of their rights. The Oxford/AstraZeneca group intends its vaccine to be for the world; will our Government help it to deliver that?